This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dr. Reddy's Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript

Dr. Reddy's Laboratories (RDY)

Q1 2013 Earnings Call

July 19, 2012 9:00 am ET


Kedar Upadhye - Former Director

Umang Vohra - Chief Financial Officer, Executive Vice President and Member of Management Council

Kallam Satish Reddy - Managing Director, Chief Operating Officer, Executive Director, Member of the Management Council, Chairman of Management Committee, Member of Shareholders Grievance Committee, Member of Investment Committee and Member of Strategy Committee


Balaji V. Prasad - Barclays Capital, Research Division

Nimish Mehta - MP Advisors

Arvind Bothra - BofA Merrill Lynch, Research Division

Ravi K. Agrawal - Standard Chartered plc, Research Division

Manoj Garg - Edelweiss Capital Ltd., Research Division

Sameer Baisiwala - Morgan Stanley, Research Division

Anubhav Aggarwal - Crédit Suisse AG, Research Division

Bino Pathiparampil - IIFL Research

Bhavin Shah - Dolat Investments Ltd., Research Division

Ranjit Kapadia - Centrum Broking Private Limited, Research Division

Nitin Agarwal - IDFC Securities Ltd., Research Division

Abhay Shanbhag - Deutsche Bank AG, Research Division

Saion Mukherjee - Nomura Securities Co. Ltd., Research Division

Chirag Talati - Espirito Santo Investment Bank, Research Division



Ladies and gentlemen, good day, and welcome to Dr. Reddy's Laboratories Limited Q1 FY '13 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I would now like to hand over the conference to Mr. Kedar Upadhye. Thank you, and over to you, sir.

Kedar Upadhye

Good morning, and good evening to all, and thank you for joining us today for Dr. Reddy's Earnings Call for quarter 1 of fiscal '13.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,789.17 +69.25 0.39%
S&P 500 2,094.21 +13.80 0.66%
NASDAQ 5,136.1680 +27.5020 0.54%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs